About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 1944 blog entries.

Michigan

Sen. Santana has introduced SB 993,  a “trailer” bill that require insurers to reimburse pharmacies for the vaccination and test and treat services authorized under P.A. 97 of 2023. The bill was referred to the Senate Health Policy Committee and could see action as early as this fall.

Also in Michigan, the Department of Health, and Human Services (MDHHS) has issued a final bulletin ending three temporary COVID-19 Medicaid Pharmacy provisions due to the COVID-19 PHE.

  • HASA 22-02 – Authorization of U.S. Food & Drug Administration (FDA) Emergency Use Authorization (EUA) pharmacist prescriptive authority of oral antivirals for the treatment of COVID-19;
  • MMP 22-29 – Coverage of FDA EUA COVID-19 monoclonal antibody injections by pharmacy providers; and
  • L 22-04 – Stand-alone vaccine counseling services billed as a Medication Therapy Management service.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-09-19T10:48:17-04:00September 19, 2024|Michigan|

Minnesota

DHS has published a  provider update with details about the November 4th transition to the new claims processing system.  On October 16 they will host what they anticipate will be the last provider virtual meeting prior to implementation and have posted the call in information. Lastly, they have also released the payer specification document for claims processing and billing.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-09-19T10:47:37-04:00September 19, 2024|Minnesota|

New Hampshire

The New Hampshire Board of Pharmacy will be holding a hearing on September 25, 2025, at 9:30 am to review the repeal of three rules.  The three rules being repealed are (1) in regard to unused prescription drugs, (2) the New Hampshire Controlled Drug Prescription Health and Safety Program, and (3) Continuous Quality Improvement.  In lieu of attending, written comments can be submitted to OPLC-Rules@oplc.nh.gov.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2024-09-19T10:47:02-04:00September 19, 2024|New Hampshire|

New York

On September 5, Governor Hochul signed into law the Retail Workers Safety Act, which requires employers to implement policies and training programs to prevent workplace violence. It requires a retail store with 500 or more employees to install panic buttons in all New York locations. The Department of Labor would be required to create a model workplace violence prevention training program, policy, and guidance document to be utilized by employers. The law is effective March 4, 2025, however the section requiring panic buttons would take effect January 1, 2027.

On September 13, 2024, the New York Pharmacy Conference held its regular meeting. The meeting included updates from Donate Life New York State, the Comprehensive Contraceptive Coverage Act, and Expansion of Collaborative Drug Therapy Management to offsite practices, and a legislative update from Assemblyman John McDonald. The next meeting of the conference will be held on Friday December 13, 2024, at 10 AM.

On September 18, 2024, the New York Department of Health held their monthly pharmacy industry call regarding NYRx, the Medicaid Fee-For-Service Program. This month’s call included updates on Blood Glucose Test Strip Coverage Policy and Covid Tests Coverage Policy Update.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2024-09-19T10:46:14-04:00September 19, 2024|New York|

Ohio

2024-09-19T10:45:39-04:00September 19, 2024|Ohio|

Oregon

The Prescription Drug Affordability Board (PDAB) moved its next meeting from September 18 to October 2 due to unforeseen scheduling issues and lack of a quorum. The agenda has been updated to reflect this change. Please note the “Medicare MFP modeling presentation and SB 192 upper payment limit discussion” by PDAB staff and Myers and Stauffer on the agenda. You must register in advance of the meeting to participate.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-09-19T10:44:57-04:00September 19, 2024|Oregon|

Tennessee

Effective October 1, 2024, over the Counter (OTC) COVID-19 testing kits will no longer be covered under TennCare’s pharmacy benefit due to the end of the COVID-19 Public Health Emergency. Beginning October 1, 2024, Covid Test Kits will remain a covered benefit under the medical benefit.

Effective September 1, 2024, TennCare began reimbursing pharmacy providers through the OptumRx Pharmacy Point of Sale System (POS) for the administration of newly FDA approved COVID-19 vaccines for the 2024-2025 Formulas. Per FDA guidance, previous versions of COVID-19 vaccines are no longer recommended or authorized for use. CoverKids and CoverRx claims also follow this FDA guidance.

Claims for COVID-19 vaccines are exempt from co-pays and script limits for all TennCare enrollees.

COVID vaccine claims for dual eligible members (Both Medicare and Medicaid eligible) will receive NCPDP Reject 65 “Patient has Medicare Coverage, Bill Medicare.”

Please note for TennCare members, effective October 1, 2024, the Covid-19 vaccine reimbursement will change to include only the cost of the vaccine plus the Professional Dispensing Fee (PDF). The $40 administration fee will be discontinued. Therefore, the Incentive Amount Submitted (NCPDP Field 483-E3) is no longer required for claim submission. If you have a TennCare Medicaid ID, you may contract with the individual Managed Care Organization(s) to bill for ancillary services. Please contact the designated health plan Provider Services for assistance.

Also in Tennessee, prior authorization requirements can be bypassed for certain medications when specific medical conditions exist. The submitted claim should include a Diagnosis Code Qualifier (Field # 492- WE) of “02,” indicating ICD-10, as well as the appropriate Diagnosis Code (Field # 424-DO). See a list of the preferred agents and the clinical criteria here, and see the list of Tennessee OptumRx Provider Liaisons here.

Finally in Tennessee, the Tennessee Pharmacists Research and Education Foundation (TPREF) is proud to offer an ACPE-accredited OSHA training webinar that meets all of OSHA’s annual training requirements, with ten sessions offered between September 25 and October 23. Register for one of the sessions!

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2024-09-19T10:44:17-04:00September 19, 2024|Tennessee|

Texas

The Texas Pharmaceutical Initiative (TPI) Board is meeting on September 23.

Also in Texas, Speaker Dade Phelan (R) appointed Rick Perry (R), former Governor of Texas and Secretary of Energy under the Trump Administration, as a senior advisor to his leadership team.

Also in Texas, the Department of State Health Services (DSHS) resolved the issue of providers receiving errors when submitting Unsolicited Vaccine Updates (VXU) messages through data exchange for influenza vaccines. The seasonal influenza vaccines for 2024–2025 have been updated in ImmTrac2 as of Aug 30, 2024. Please refer to the Fall Season Respiratory Vaccine Codes | Immunization Information Systems (IIS) | CDC for the correct codes to report for influenza 2024–2025 vaccines to ImmTrac2.

Finally in Texas, the Senate Health and Human Services Committee held a hearing focused on expanding access to healthcare services and NACDS submitted a support letter.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-09-19T10:43:39-04:00September 19, 2024|Texas|

Vermont

The Board of Pharmacy will be holding its regularly scheduled meeting on September 25, 2024, at 9:00 am. The meeting will be hybrid and recorded.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2024-09-19T10:42:45-04:00September 19, 2024|Vermont|
Go to Top